These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 37504084)
1. Early Screening of Colorectal Precancerous Lesions Based on Combined Measurement of Multiple Serum Tumor Markers Using Artificial Neural Network Analysis. Ke X; Liu W; Shen L; Zhang Y; Liu W; Wang C; Wang X Biosensors (Basel); 2023 Jun; 13(7):. PubMed ID: 37504084 [TBL] [Abstract][Full Text] [Related]
2. Serum macrophage inhibitory cytokine-1 serves as a novel diagnostic biomarker of early-stage colorectal cancer. Dai C; Zhang X; Ma Y; Chen Z; Chen S; Zhang Y; Li M Biomarkers; 2021 Nov; 26(7):598-605. PubMed ID: 34266319 [TBL] [Abstract][Full Text] [Related]
3. Artificial neural network-based diagnostic models for lung cancer combining conventional indicators with tumor markers. Luo Y; Yuan H; Pei Q; Chen Y; Xian J; Du R; Ye T Exp Biol Med (Maywood); 2023 May; 248(10):829-838. PubMed ID: 37403334 [TBL] [Abstract][Full Text] [Related]
4. Role of serum Metadherin mRNA expression in the diagnosis and prediction of survival in patients with colorectal cancer. Abdel Ghafar MT; Gharib F; Abdel-Salam S; Elkhouly RA; Elshora A; Shalaby KH; El-Guindy D; El-Rashidy MA; Soliman NA; Abu-Elenin MM; Allam AA Mol Biol Rep; 2020 Apr; 47(4):2509-2519. PubMed ID: 32088817 [TBL] [Abstract][Full Text] [Related]
5. Application of Artificial Neural Network in miRNA Biomarker Selection and Precise Diagnosis of Colorectal Cancer. Afshar S; Afshar S; Warden E; Manochehri H; Saidijam M Iran Biomed J; 2019 May; 23(3):175-83. PubMed ID: 30056689 [TBL] [Abstract][Full Text] [Related]
6. [Establishment of artificial neural network model for predicting lymph node metastasis in patients with stage Ⅱ-Ⅲ gastric cancer]. Xue Z; Lu J; Lin J; Huang CM; Li P; Xie JW; Wang JB; Lin JX; Chen QY; Zheng CH Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Apr; 25(4):327-335. PubMed ID: 35461201 [No Abstract] [Full Text] [Related]
7. Comparison between Clinical Utility of CXCL-8 and Clinical Practice Tumor Markers for Colorectal Cancer Diagnosis. Huang Z; Li Z; Chen X; Zhu X; Zhang J; Song Y; Cao Y; Lu P Biomed Res Int; 2022; 2022():1213968. PubMed ID: 36567905 [TBL] [Abstract][Full Text] [Related]
8. The effect of artificial neural network model combined with six tumor markers in auxiliary diagnosis of lung cancer. Feng F; Wu Y; Wu Y; Nie G; Ni R J Med Syst; 2012 Oct; 36(5):2973-80. PubMed ID: 21882004 [TBL] [Abstract][Full Text] [Related]
9. Can preoperative CEA and CA19-9 serum concentrations suggest metastatic disease in colorectal cancer patients? Stojkovic Lalosevic M; Stankovic S; Stojkovic M; Markovic V; Dimitrijevic I; Lalosevic J; Petrovic J; Brankovic M; Pavlovic Markovic A; Krivokapic Z Hell J Nucl Med; 2017; 20(1):41-45. PubMed ID: 28315907 [TBL] [Abstract][Full Text] [Related]
10. Non-invasive prediction of microsatellite instability in colorectal cancer by a genetic algorithm-enhanced artificial neural network-based CT radiomics signature. Chen X; He L; Li Q; Liu L; Li S; Zhang Y; Liu Z; Huang Y; Mao Y; Chen X Eur Radiol; 2023 Jan; 33(1):11-22. PubMed ID: 35771245 [TBL] [Abstract][Full Text] [Related]
11. The Diagnosis Significance of Serum Cysteine Protease Inhibitors (CST4) in Colorectal Cancer. Huang M; Yang Z; Ren J; Wang T; Chen D; Zhan Y; Le W; Deng S Technol Cancer Res Treat; 2023; 22():15330338231164232. PubMed ID: 37122229 [TBL] [Abstract][Full Text] [Related]
12. Alu-based cell-free DNA: a potential complementary biomarker for diagnosis of colorectal cancer. Qi J; Qian C; Shi W; Wu X; Jing R; Zhang L; Wang Z; Ju S Clin Biochem; 2013 Jan; 46(1-2):64-9. PubMed ID: 22975639 [TBL] [Abstract][Full Text] [Related]
13. Clinical Value of Serum p53 Antibody in the Diagnosis and Prognosis of Colorectal Cancer. Kunizaki M; Sawai T; Takeshita H; Tominaga T; Hidaka S; To K; Miyazaki T; Hamamoto R; Nanashima A; Nagayasu T Anticancer Res; 2016 Aug; 36(8):4171-5. PubMed ID: 27466527 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of multiple biological indicators for the combined diagnosis of metastases from colorectal cancer-a retrospective study based on 1163 patients. Chen B; Zhou J; Ma Y; Sun Q; Ren J; Wang D World J Surg Oncol; 2023 Jul; 21(1):229. PubMed ID: 37501060 [TBL] [Abstract][Full Text] [Related]
15. Serum IgG N-glycans enable early detection and early relapse prediction of colorectal cancer. Gu Y; Duan B; Sha J; Zhang R; Fan J; Xu X; Zhao H; Niu X; Geng Z; Gu J; Huang B; Ren S Int J Cancer; 2023 Feb; 152(3):536-547. PubMed ID: 36121650 [TBL] [Abstract][Full Text] [Related]
16. Diagnostic value of carcinoembryonic antigen and carcinoma antigen 19-9 for colorectal carcinoma. Zhang SY; Lin M; Zhang HB Int J Clin Exp Pathol; 2015; 8(8):9404-9. PubMed ID: 26464695 [TBL] [Abstract][Full Text] [Related]
17. Multiplex quantitation of 270 plasma protein markers to identify a signature for early detection of colorectal cancer. Bhardwaj M; Weigl K; Tikk K; Holland-Letz T; Schrotz-King P; Borchers CH; Brenner H Eur J Cancer; 2020 Mar; 127():30-40. PubMed ID: 31972396 [TBL] [Abstract][Full Text] [Related]
18. Feasibility of CYFRA 21-1 as a serum biomarker for the detection of colorectal adenoma and advanced colorectal adenoma in people over the age of 45. Lim DH; Lee JH; Kim JW J Clin Lab Anal; 2018 Jan; 32(1):. PubMed ID: 28186354 [TBL] [Abstract][Full Text] [Related]
19. Serum miR-372 is a Diagnostic and Prognostic Biomarker in Patients with Early Colorectal Cancer. Yu J; Jin L; Jiang L; Gao L; Zhou J; Hu Y; Li W; Zhi Q; Zhu X Anticancer Agents Med Chem; 2016; 16(4):424-31. PubMed ID: 26179262 [TBL] [Abstract][Full Text] [Related]
20. Novel DNA methylation biomarkers in stool and blood for early detection of colorectal cancer and precancerous lesions. Shen Y; Wang D; Yuan T; Fang H; Zhu C; Qin J; Xu X; Zhang C; Liu J; Zhang Y; Wen Z; Tang J; Wang Z Clin Epigenetics; 2023 Feb; 15(1):26. PubMed ID: 36803423 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]